Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Non-Current Deffered Revenue (2016 - 2019)

Historic Non-Current Deffered Revenue for Bristol Myers Squibb (BMYMP) over the last 11 years, with Q1 2019 value amounting to $448.0 million.

  • Bristol Myers Squibb's Non-Current Deffered Revenue rose 22.37% to $448.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $448.0 million, marking a year-over-year increase of 22.37%. This contributed to the annual value of $468.0 million for FY2018, which is 308.37% up from last year.
  • According to the latest figures from Q1 2019, Bristol Myers Squibb's Non-Current Deffered Revenue is $448.0 million, which was up 22.37% from $468.0 million recorded in Q4 2018.
  • Bristol Myers Squibb's Non-Current Deffered Revenue's 5-year high stood at $697.0 million during Q1 2015, with a 5-year trough of $447.0 million in Q1 2018.
  • In the last 5 years, Bristol Myers Squibb's Non-Current Deffered Revenue had a median value of $528.0 million in 2017 and averaged $542.5 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first tumbled by 3598.85% in 2015, then surged by 308.37% in 2018.
  • Bristol Myers Squibb's Non-Current Deffered Revenue (Quarter) stood at $586.0 million in 2015, then decreased by 6.66% to $547.0 million in 2016, then decreased by 17.0% to $454.0 million in 2017, then rose by 3.08% to $468.0 million in 2018, then fell by 4.27% to $448.0 million in 2019.
  • Its last three reported values are $448.0 million in Q1 2019, $468.0 million for Q4 2018, and $486.0 million during Q3 2018.